FDA Readies Guidelines, Warns Bristol-Myers

Inspiration meets innovation at Brandweek, the ultimate marketing experience. Join industry luminaries, rising talent and strategic experts in Phoenix, Arizona this September 23–26 to assess challenges, develop solutions and create new pathways for growth. Register early to save.

WASHINGTON, D.C. The Food and Drug Administra-
tion will issue new guidelines for direct-to-consumer ads for prescription drugs, FDA Commissioner Mark McClellan said on Friday.

The guidelines, which will be announced in the fall, come as the FDA is stepping up its enforcement of rules against misleading drug ads.

“It is more important than ever for Americans to be protected from misleading claims not based on scientific fact,” McClellan said at a luncheon at the National Press Club.

The






AW+

WORK SMARTER - LEARN, GROW AND BE INSPIRED.

Spring Special

Save 30% Off an ADWEEK Subscription Today!

View Your Options

Already a member? Sign in